Adrenomedullin prevents apoptosis in prostate cancer cells

Regulatory Peptides

Volumn 133, Issue 1-3, 2006, Pages 115-122

  Abasolo, Ibane ^a   Montuenga, Luis M ^a   Calvo, Alfonso ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adrenomedullin; Apoptosis; Bax; Bcl 2

Indexed keywords

ADRENOMEDULLIN; ANTINEOPLASTIC AGENT; ETOPOSIDE; GYRASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STRAIN LNCAP; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ADRENOMEDULLIN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEPTIDES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 29244468888     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2005.09.026     Document Type: Article

References (44)

1. R.T. Greenlee, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 2000 CA Cancer J Clin 50 1 2000 7 33
2. S.S. Wilson, and E.D. Crawford Screening for prostate cancer: current recommendations Urol Clin North Am 31 2 2004 219 226
3. G.V. Glinsky, A.B. Glinskii, A.J. Stephenson, R.M. Hoffman, and W.L. Gerald Gene expression profiling predicts clinical outcome of prostate cancer J Clin Invest 113 6 2004 913 923
4. Z. Culig, A. Hobisch, M.V. Cronauer, C. Radmayr, A. Hittmair, and J. Zhang Regulation of prostatic growth and function by peptide growth factors Prostate 28 6 1996 392 405
5. K. Kitamura, J. Sakata, K. Kangawa, M. Kojima, H. Matsuo, and T. Eto Cloning and characterization of cDNA encoding a precursor for human adrenomedullin Biochem Biophys Res Commun 194 2 1993 720 725
6. N. Jiménez, A. Calvo, A. Martinez, D. Rosell, F. Cuttitta, and L.M. Montuenga Expression of adrenomedullin and proadrenomedullin N-terminal 20 peptide in human and rat prostate J Histochem Cytochem 47 9 1999 1167 1178
7. P. Rocchi, F. Boudouresque, A.J. Zamora, X. Muracciole, E. Lechevallier, and P.M. Martin Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines Cancer Res 61 3 2001 1196 1206
8. N. Jiménez, J. Jongsma, A. Calvo, T.H. van der Kwast, A.M. Treston, and F. Cuttitta Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma Mol Carcinog 38 1 2003 14 24
9. N. Jimenez, I. Abasolo, J. Jongsma, A. Calvo, M. Garayoa, and T.H. van der Kwast Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma Mol Carcinog 38 1 2003 14 24
10. P. Rocchi, X. Muracciole, F. Fina, D.J. Mulholland, G. Karsenty, and J. Palmari Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft Oncogene 23 56 2004 9111 9119
11. J.P. Hinson, S. Kapas, and D.M. Smith Adrenomedullin, a multifunctional regulatory peptide Endocr Rev 21 2 2000 138 167
12. I. Abasolo, L. Yang, R. Haleem, W. Xiao, R. Pio, and F. Cuttitta Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo Mol Cell Endocrinol 199 1-2 2003 179 187
13. I. Abasolo, Z. Wang, L.M. Montuenga, and A. Calvo Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-independent autocrine mechanism Biochem Biophys Res Commun 322 3 2004 878 886
14. O. Gonzalez-Moreno, A. Calvo, B.H. Joshi, I. Abasolo, P. Leland, and Z. Wang Gene expression profiling identifies IL-13 receptor alpha2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin Int J Cancer 17 2004 17
15. L.M. McLatchie, N.J. Fraser, M.J. Main, A. Wise, J. Brown, and N. Thompson RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor Nature 393 6683 1998 333 339
16. A. Martinez, M. Vos, L. Guedez, G. Kaur, Z. Chen, and M. Garayoa The effects of adrenomedullin overexpression in breast tumor cells J Natl Cancer Inst 94 16 2002 1226 1237
17. M.K. Oehler, C. Norbury, S. Hague, M.C. Rees, and R. Bicknell Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth Oncogene 20 23 2001 2937 2945
18. M. Sata, M. Kakoki, D. Nagata, H. Nishimatsu, E. Suzuki, and T. Aoyagi Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism Hypertension 36 1 2000 83 88
19. K.H. Hofbauer, E. Schoof, A. Kurtz, and P. Sandner Inflammatory cytokines stimulate adrenomedullin expression through nitric oxide-dependent and -independent pathways Hypertension 39 1 2002 161 167
20. M. Shichiri, H. Kato, M. Doi, F. Marumo, and Y. Hirata Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis Mol Endocrinol 13 8 1999 1353 1363
21. C. Guo, L.M. Luttrell, and D.T. Price Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines J Urol 163 3 2000 1027 1032
22. W.D. Jarvis, C.R. Johnson, F.A. Fornari, J.S. Park, P. Dent, and S. Grant Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation J Pharmacol Exp Ther 290 3 1999 1384 1392
23. S.A. Park, H.J. Park, B.I. Lee, Y.H. Ahn, S.U. Kim, and K.S. Choi Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells Brain Res Mol Brain Res 93 1 2001 18 26
24. A. Zetterberg, O. Larsson, and K.G. Wiman What is the restriction point? Curr Opin Cell Biol 7 6 1995 835 842
25. K.R. Hande Etoposide: four decades of development of a topoisomerase II inhibitor Eur J Cancer 34 10 1998 1514 1521
26. G. Chen, J. Shu, and D.W. Stacey Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide Oncogene 15 14 1997 1643 1651
27. M.M. Webber, D. Bello, and S. Quader Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications Prostate 30 2 1997 136 142
28. M. Marcelli, M. Marani, X. Li, L. Sturgis, S.J. Haidacher, and J.A. Trial Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation Prostate 42 4 2000 260 273
29. A. Martinez, M. Vos, L. Guedez, G. Kaur, Z. Chen, and M. Garayoa The effects of adrenomedullin overexpression in breast tumor cells J Natl Cancer Inst 94 16 2002 1226 1237
30. Z. Li, S. Takeuchi, N. Ohara, and T. Maruo Paradoxically abundant expression of Bcl-2 and adrenomedullin in invasive cervical squamous carcinoma Int J Clin Oncol 8 2 2003 83 89
31. K. Kato, H. Yin, J. Agata, H. Yoshida, L. Chao, and J. Chao Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion Am J Physiol Heart Circ Physiol 285 4 2003 H1506 H1514 (Epub 2003 Jun 12)
32. D.L. Persons, E.M. Yazlovitskaya, W. Cui, and J.C. Pelling Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin Clin Cancer Res 5 5 1999 1007 1014
33. M. Garayoa, A. Martinez, S. Lee, R. Pio, W.G. An, and L. Neckers Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis Mol Endocrinol 14 6 2000 848 862
34. M. Hockel, K. Schlenger, S. Hockel, and P. Vaupel Hypoxic cervical cancers with low apoptotic index are highly aggressive Cancer Res 59 18 1999 4525 4528
35. S. Iimuro, T. Shindo, N. Moriyama, T. Amaki, P. Niu, and N. Takeda Angiogenic effects of adrenomedullin in ischemia and tumor growth Circ Res 95 4 2004 415 423 (Epub 2004 Jul 8)
36. T. Tsuruda, J. Kato, Y.N. Cao, K. Hatakeyama, H. Masuyama, and T. Imamura Adrenomedullin induces matrix metalloproteinase-2 activity in rat aortic adventitial fibroblasts Biochem Biophys Res Commun 325 1 2004 80 84
37. Y. Fujita, H. Mimata, N. Nasu, T. Nomura, Y. Nomura, and M. Nakagawa Involvement of adrenomedullin induced by hypoxia in angiogenesis in human renal cell carcinoma Int J Urol 9 6 2002 285 295
38. A. Jogi, J. Vallon-Christersson, L. Holmquist, H. Axelson, A. Borg, and S. Pahlman Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior Exp Cell Res 295 2 2004 469 487
39. K. Vermeulen, Z.N. Berneman, and D.R. Van Bockstaele Cell cycle and apoptosis Cell Prolif 36 3 2003 165 175
40. B. Pucci, M. Kasten, and A. Giordano Cell cycle and apoptosis Neoplasia 2 4 2000 291 299
41. S.K. Oster, C.S. Ho, E.L. Soucie, and L.Z. Penn The myc oncogene: marvelouslY complex Adv Cancer Res 84 2002 81 154
42. H. Zhang, S. Fan, and E.V. Prochownik Distinct roles for MAX protein isoforms in proliferation and apoptosis J Biol Chem 272 28 1997 17416 17424
43. Z. Kolar, P.G. Murray, K. Scott, A. Harrison, B. Vojtesek, and J. Dusek Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer Mol Pathol 53 1 2000 15 18
44. R.N. Coffey, R.W. Watson, P.K. Hegarty, C.L. Watson, L. Wolohan, and H.R. Brady Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases Cancer 92 9 2001 2297 2308